Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Nu-Med Plus (NUMD) Gains from Investment Securities (2016 - 2021)

Nu-Med Plus' Gains from Investment Securities history spans 6 years, with the latest figure at $40353.0 for Q4 2021.

  • Quarterly results put Gains from Investment Securities at $40353.0 for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $52287.0 (up 123.9% YoY), and the annual figure for FY2021 was $52000.0, up 335.73%.
  • Gains from Investment Securities for Q4 2021 was $40353.0 at Nu-Med Plus, up from $11934.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $40353.0 in Q4 2021 to a low of $11419.0 in Q3 2019.
  • The 3-year median for Gains from Investment Securities is $11934.0 (2020), against an average of $21235.3.
  • Peak annual rise in Gains from Investment Securities hit 4.51% in 2020, while the deepest fall reached 4.51% in 2020.
  • Year by year, Gains from Investment Securities stood at $11419.0 in 2019, then rose by 4.51% to $11934.0 in 2020, then surged by 238.13% to $40353.0 in 2021.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $40353.0, $11934.0, and $11419.0 for Q4 2021, Q3 2020, and Q3 2019 respectively.